14 Results for "

Mereletinib

" in MedChemExpress (MCE) Product Catalog:
Products (14)

14 Results for "Mereletinib" in MCE Product Catalog:

214
214 Publications Verification
Cat. No.: HY-15772
CAS No.: 1421373-65-0
Purity:  99.92%
Synonyms: AZD-9291; Mereletinib
Target:  

EGFR

Research Areas:  

Cancer

Osimertinib (AZD9291) is a covalent, orally active, irreversible, and mutant-selective EGFR inhibitor with an apparent IC50 of 12 nM against L858R and 1 nM against L858R/T790M, respectively. Osimertinib overcomes T790M-mediated resistance to EGFR inhibitors in lung cancer .
loading...
    loading...
214
214 Publications Verification
Cat. No.: HY-15772A
CAS No.: 1421373-66-1
Purity:  99.97%
Synonyms: AZD-9291 mesylate; Mereletinib mesylate
Target:  

EGFR

Research Areas:  

Cancer

Osimertinib mesylate (AZD9291 mesylate) is a covalent, orally active, irreversible, and mutant-selective EGFR inhibitor with an apparent IC50 of 12 nM against L858R and 1 nM against L858R/T790M. Osimertinib overcomes T790M-mediated resistance to EGFR inhibitors in lung cancer .
loading...
    loading...
214
214 Publications Verification
Cat. No.: HY-79077
CAS No.: 2070014-82-1
Synonyms: AZD-9291 dimesylate; Mereletinib dimesylate
Target:  

EGFR

Research Areas:  

Cancer

Osimertinib dimesylate (AZD-9291 dimesylate) is an irreversible and mutant selective EGFR inhibitor with IC50s of 12 and 1 nM against EGFR L858R and EGFR L858R/T790M, respectively.
loading...
    loading...
Cat. No.: HY-15772R
CAS No.: 1421373-65-0
Synonyms: AZD-9291 (Standard); Mereletinib (Standard)
Research Areas:  

Cancer

Osimertinib (Standard) is the analytical standard of Osimertinib. This product is intended for research and analytical applications. Osimertinib (AZD9291) is a covalent, orally active, irreversible, and mutant-selective EGFR inhibitor with an apparent IC50 of 12 nM against L858R and 1 nM against L858R/T790M, respectively. Osimertinib overcomes T790M-mediated resistance to EGFR inhibitors in lung cancer .
loading...
    loading...
Cat. No.: HY-15772S1
CAS No.: 2254100-49-5
Synonyms: AZD-9291-13C,d3; Mereletinib-13C,d3
Osimertinib- 13C,d3 is the deuterium and 13C labeled Osimertinib. Osimertinib (AZD9291) is a covalent, orally active, irreversible, and mutant-selective EGFR inhibitor with an apparent IC50 of 12 nM against L858R and 1 nM against L858R/T790M, respectively.
loading...
    loading...
Cat. No.: HY-15772S
CAS No.: 1638281-44-3
Purity:  99.97%
Synonyms: AZD-9291-d6; Mereletinib-d6
Osimertinib-d6 is a deuterium labeled osimertinib. Osimertinib is a covalent, orally active, irreversible, and mutant-selective EGFR inhibitor with an apparent IC50 of 12 nM against L858R and 1 nM against L858R/T790M. Osimertinib overcomes T790M-mediated resistance to EGFR inhibitors in lung cancer .
loading...
    loading...
Cat. No.: HY-15772AR
CAS No.: 1421373-66-1
Synonyms: AZD-9291 mesylate (Standard); Mereletinib mesylate (Standard)
Research Areas:  

Cancer

Osimertinib (mesylate) (Standard) is the analytical standard of Osimertinib (mesylate). This product is intended for research and analytical applications. Osimertinib mesylate (AZD9291 mesylate) is a covalent, orally active, irreversible, and mutant-selective EGFR inhibitor with an apparent IC50 of 12 nM against L858R and 1 nM against L858R/T790M. Osimertinib overcomes T790M-mediated resistance to EGFR inhibitors in lung cancer .
loading...
    loading...
Cat. No.: HY-142283AS
CAS No.: 2403760-72-3
Purity:  99.44%
Synonyms: Osimertinib-d5 mesylate; AZD-9291-d5 mesylate; Mereletinib-d5 mesylate
Target:  

EGFR

Research Areas:  

Cancer

Dosimertinib mesylate is a potent and orally active EGFR inhibitor. Dosimertinib mesylate decreases the expression of p-EGFR and p-ERK protein levels. Dosimertinib mesylate shows antiproliferative and anti-tumor activity. Dosimertinib mesylate has the potential for the research of non-small-cell lung cancer (NSCLC) .
loading...
    loading...
Cat. No.: HY-142283
CAS No.: 2403760-70-1
Synonyms: Osimertinib-d5; AZD-9291-d5; Mereletinib-d5
Research Areas:  

Cancer

Dosimertinib is a potent and orally active EGFR inhibitor. Dosimertinib decreases the expression of p-EGFR and p-ERK protein levels. Dosimertinib shows antiproliferative and anti-tumor activity. Dosimertinib has the potential for the research of non-small-cell lung cancer (NSCLC) .
loading...
    loading...
Cat. No.: HY-79077R
CAS No.: 2070014-82-1
Synonyms: AZD-9291 dimesylate (Standard); Mereletinib dimesylate (Standard)
Research Areas:  

Cancer

Osimertinib (dimesylate) (Standard) is the analytical standard of Osimertinib (dimesylate). This product is intended for research and analytical applications. Osimertinib dimesylate (AZD-9291 dimesylate) is an irreversible and mutant selective EGFR inhibitor with IC50s of 12 and 1 nM against EGFRL858R and EGFRL858R/T790M, respectively.
loading...
    loading...
Cat. No.: HY-142283BS
CAS No.: 2719691-00-4
Synonyms: N-Desmethyl Osimertinib-d5; N-Desmethyl AZD-9291-d5; N-Desmethyl Mereletinib-d5
Target:  

EGFR

Research Areas:  

Cancer

N-Desmethyl dosimertinib is the deuterium labeled N-Desmethyl dosimertinib.
loading...
    loading...
Cat. No.: HY-142283CS
CAS No.: 2719690-98-7
Synonyms: N-Methyl-Osimertinib-d5; N-Methyl-AZD-9291-d5; N-Methyl-Mereletinib-d5
Target:  

EGFR

Research Areas:  

Cancer

N-Methyl-dosimertinib is the deuterium labeled of N-Methyl-osimertinib.
loading...
    loading...
  • 1